Current strategies for the management of bleeding associated with direct oral anticoagulants and a review of investigational reversal agents
from The Journal of Emergency Medicine
The management of life-threatening bleeding in patients who are receiving direct oral anticoagulants (DOACs) is a serious medical concern. This review provides a concise, balanced overview of the current and future approaches for reversing the anticoagulation effects of DOACs, particularly factor Xa (FXa) inhibitors.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063